Characterization of a Major Histocompatibility Complex Class II X-Box-Binding Protein Enhancing Tat-Induced Transcription Directed by the Human Immunodeficiency Virus Type 1 Long Terminal Repeat

ABSTRACT The X-box element present within the promoter region of genes belonging to the major histocompatibility complex (MHC) plays a pivotal role in the expression of class II molecules, since it contains the binding sites for several well-characterized transcription factors. We have analyzed a randomly selected compilation of viral genomes for the presence of elements homologous to the X box of the HLA-DRA gene. We found that human immunodeficiency virus type 1 (HIV-1) shows the highest frequency of X-like box elements per 1,000 bases of genome. Within the HIV-1 genome, we found an X-like motif in the TAR region of the HIV-1 long terminal repeat (LTR), a regulative region playing a pivotal role in Tat-induced HIV-1 transcription. The use of a decoy approach for nuclear proteins binding to this element, namely, XMAS (X-like motif activator sequence), performed by transfection of multiple copies of this sequence into cells carrying an integrated LTR-chloramphenicol acetyltransferase construct, suggests that this element binds to nuclear proteins that enhance Tat-induced transcription. In this report we have characterized two proteins, one binding to the XMAS motif and the other to the flanking regions of XMAS. Mobility shift assays performed on crude nuclear extracts or enriched fractions suggest that similar proteins bind to XMAS from HIV-1 and the X box of the HLA-DRA gene. Furthermore, a UV cross-linking assay suggests that one protein of 47 kDa, termed FAX (factor associated with XMAS)-1, binds to the XMAS of HIV-1. The other protein of 56 kDa was termed FAX-2. In a decoy ex vivo experiment, it was found that sequences recognizing both proteins are required to inhibit Tat-induced HIV-1 LTR-driven transcription. Taken together, the data reported in this paper suggest that XMAS and nearby sequences modulate Tat-induced HIV-1 transcription by binding to the X-box-binding proteins FAX-1 and FAX-2. The sequence homology between XMAS and X box is reflected in binding of a common protein, FAX-1, and similar functional roles in gene expression. To our knowledge, this is the first report showing that transcription factors binding to the X box of the MHC class II genes enhance the transcription of HIV-1.

[1]  N. Hernandez,et al.  Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs , 1993, Molecular and cellular biology.

[2]  R. Gaynor,et al.  Transcription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expression , 1994, Journal of virology.

[3]  P. Sharp,et al.  HIV‐1 Tat protein promotes formation of more‐processive elongation complexes. , 1991, The EMBO journal.

[4]  M. Mathews,et al.  HIV-1 Tat overcomes inefficient transcriptional elongation in vitro. , 1993, Journal of molecular biology.

[5]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[6]  J. Ting,et al.  Regulation of MHC gene expression. , 1993, Current opinion in immunology.

[7]  B. Cullen The HIV-1 Tat protein: An RNA sequence-specific processivity factor? , 1990, Cell.

[8]  R. Gaynor,et al.  Cellular transcription factors involved in the regulation of HIV-1 gene expression. , 1992, AIDS.

[9]  R. Roeder,et al.  Human transcription factor USF stimulates transcription through the initiator elements of the HIV‐1 and the Ad‐ML promoters. , 1993, The EMBO journal.

[10]  R. Gambari,et al.  Sequence-specific recognition of the HIV-1 long terminal repeat by distamycin: a DNAase I footprinting study. , 1994, The Biochemical journal.

[11]  R. Roeder,et al.  An alternative pathway for transcription initiation involving TFII-I , 1993, Nature.

[12]  W. Reith,et al.  Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X , 1988, Cell.

[13]  B. Peterlin,et al.  Affinity enrichment and functional characterization of TRAX1, a novel transcription activator and X1-sequence-binding protein of HLA-DRA , 1995, Molecular and cellular biology.

[14]  B. Peterlin,et al.  Control of RNA initiation and elongation at the HIV-1 promoter. , 1994, Annual review of biochemistry.

[15]  K. Jeang,et al.  Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat* , 1999, The Journal of Biological Chemistry.

[16]  P. Cresswell Questions of presentation , 1990, Nature.

[17]  J. Guardiola,et al.  Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases. , 1993, Critical reviews in immunology.

[18]  J. Trowsdale,et al.  Complete nucleotide sequence of a functional HLA-DPβ gene and the region between the DPβ1 and DPα1 genes: comparison of the 5′ ends of HLA class II genes , 1985 .

[19]  C. Benoist,et al.  Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. , 1990, Annual review of immunology.

[20]  P. Luciw,et al.  Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters. , 1988, Genes & development.

[21]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[22]  M. Nakanishi,et al.  Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors , 1990, Molecular and cellular biology.

[23]  A. Das Control of transcription termination by RNA-binding proteins. , 1993, Annual review of biochemistry.

[24]  D. Margolis,et al.  Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production , 1994, Journal of virology.

[25]  B. Durand,et al.  Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX , 1994, Molecular and cellular biology.

[26]  C. Benoist,et al.  The immune system of mice lacking conventional MHC class II molecules. , 1994, Advances in immunology.

[27]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[28]  L. Glimcher,et al.  Immune responses in MHC class II-deficient mice. , 1995, Annual Review of Immunology.

[29]  J. Karn,et al.  Tackling Tat. , 1999, Journal of molecular biology.

[30]  R. Roeder,et al.  Characterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vitro , 1994, Molecular and cellular biology.

[31]  A. Frankel Activation of HIV transcription by Tat , 1992, Current Biology.

[32]  D Harrich,et al.  Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs , 1995, Journal of virology.

[33]  M. Mathews,et al.  Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. , 1990, Genes & development.

[34]  P. Sharp,et al.  Novel mechanism and factor for regulation by HIV‐1 Tat. , 1995, The EMBO journal.

[35]  R. Roeder,et al.  Cooperative interaction of an initiator-binding transcription initiation factor and the helix–loop–helix activator USF , 1991, Nature.

[36]  J. Karn,et al.  Human immunodeficiency virus type 1 transactivator protein, tat, stimulates transcriptional read-through of distal terminator sequences in vitro. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  W. Reith,et al.  Regulation of MHC class II genes: lessons from a disease. , 1996, Annual review of immunology.

[38]  N. Zeleznik-Le,et al.  Transcriptional regulation of the HLA-DRA gene. , 1991, Critical reviews in immunology.

[39]  M. Mathews,et al.  HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation , 1989, Cell.

[40]  L. Glimcher,et al.  Sequences and factors: a guide to MHC class-II transcription. , 1992, Annual review of immunology.

[41]  P. Sharp,et al.  HIV TAR: An RNA enhancer? , 1989, Cell.

[42]  Guangming Zhong,et al.  Chlamydia Inhibits Interferon γ–inducible Major Histocompatibility Complex Class II Expression by Degradation of  Upstream Stimulatory Factor 1 , 1999, The Journal of experimental medicine.

[43]  R. Roeder,et al.  HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. , 1992, Genes & development.

[44]  H. Wang,et al.  Identification of two factors required for transcription of the ovalbumin gene , 1986, Molecular and cellular biology.